210 related articles for article (PubMed ID: 27108935)
21. The binding orientations of structurally-related ligands can differ; A cautionary note.
Ruepp MD; Wei H; Leuenberger M; Lochner M; Thompson AJ
Neuropharmacology; 2017 Jun; 119():48-61. PubMed ID: 28137449
[TBL] [Abstract][Full Text] [Related]
22. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.
Trattnig SM; Harpsøe K; Thygesen SB; Rahr LM; Ahring PK; Balle T; Jensen AA
J Biol Chem; 2012 Jul; 287(30):25241-54. PubMed ID: 22589534
[TBL] [Abstract][Full Text] [Related]
24. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
25. Palonosetron-5-HT
Price KL; Lillestol RK; Ulens C; Lummis SC
ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Kurzwelly D; Barann M; Kostanian A; Combrink S; Bönisch H; Göthert M; Brüss M
Pharmacogenetics; 2004 Mar; 14(3):165-72. PubMed ID: 15167704
[TBL] [Abstract][Full Text] [Related]
27. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
28. Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists.
Van't Klooster MP; Foadi N; Hage A; Stoetzer C; Wegner F; Eberhardt M; Leffler A
Eur J Pharmacol; 2016 Oct; 789():119-126. PubMed ID: 27401036
[TBL] [Abstract][Full Text] [Related]
29. Effect of a novel 5-hydroxytryptamine3 (5-HT3) receptor antagonist, GK-128, on 5-HT3 receptors mediating contractions and relaxations in guinea-pig distal colon.
Ito C; Kawamura R; Isobe Y; Tsuchida K; Muramatsu M; Higuchi S
Gen Pharmacol; 1997 Sep; 29(3):353-9. PubMed ID: 9378239
[TBL] [Abstract][Full Text] [Related]
30. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
31. Muscarinic cholinergic receptors in brain and atrial membranes of adult brook trout (Salvelinus fontinalis) measured by radioligand binding techniques.
Jones SB; King LB
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Sep; 112(1):43-50. PubMed ID: 8564789
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Boess FG; de Vry J; Erb C; Flessner T; Hendrix M; Luithle J; Methfessel C; Schnizler K; van der Staay FJ; van Kampen M; Wiese WB; König G
Psychopharmacology (Berl); 2013 May; 227(1):1-17. PubMed ID: 23241647
[TBL] [Abstract][Full Text] [Related]
33. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.
Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B
Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203
[TBL] [Abstract][Full Text] [Related]
34. Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.
Lummis SC; Thompson AJ
Neuropharmacology; 2013 Oct; 73():241-6. PubMed ID: 23747573
[TBL] [Abstract][Full Text] [Related]
35. A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Sep; 170(2):391-402. PubMed ID: 23822584
[TBL] [Abstract][Full Text] [Related]
36. Yokukansan contains compounds that antagonize the 5-HT
Nakamura Y; Ishida Y; Kondo M; Shimada S
Phytomedicine; 2018 Apr; 43():120-125. PubMed ID: 29747744
[TBL] [Abstract][Full Text] [Related]
37. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
Fisher SK
Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
[TBL] [Abstract][Full Text] [Related]
38. Discriminating between 5-HT₃A and 5-HT₃AB receptors.
Thompson AJ; Lummis SC
Br J Pharmacol; 2013 Jun; 169(4):736-47. PubMed ID: 23489111
[TBL] [Abstract][Full Text] [Related]
39. The interaction of antidepressant drugs with central and peripheral (enteric) 5-HT3 and 5-HT4 receptors.
Lucchelli A; Santagostino-Barbone MG; Barbieri A; Candura SM; Tonini M
Br J Pharmacol; 1995 Mar; 114(5):1017-25. PubMed ID: 7780635
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Pharmacological Evaluation of [
Mu L; Müller Herde A; Rüefli PM; Sladojevich F; Milicevic Sephton S; Krämer SD; Thompson AJ; Schibli R; Ametamey SM; Lochner M
ACS Chem Neurosci; 2016 Nov; 7(11):1552-1564. PubMed ID: 27571447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
